pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-3057 |
Genomic Coordinates | chr10: 81271597 - 81271687 |
Description | Mus musculus miR-3057 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-3057-5p |
Sequence | 14| AUUGGAGCUGAGAUUCUGCGGGAU |37 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Atp2b2 | ||||||||||||||||||||
Synonyms | D6Abb2e, Gena300, PMCA2, Tmy, dfw, jog, wms, wri | ||||||||||||||||||||
Description | ATPase, Ca++ transporting, plasma membrane 2 | ||||||||||||||||||||
Transcript | NM_001036684 | ||||||||||||||||||||
Other Transcripts | NM_009723 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Atp2b2 | |||||||||||||||||||||
3'UTR of Atp2b2 (miRNA target sites are highlighted) |
>Atp2b2|NM_001036684|3'UTR 1 CTGAGGCCCCTGTCGCCTGGCCACGCTCATGGACCCGCCGCCACCCGCCTCCAGGCGCACACCCTTCCAGGCACCAACTC 81 CCCGACACAGCAAGGAGCACTGGGCGGAACCCACACAGCAGAGAGGGAACCAGACCTTTCTCTGGCAGCCATGCTGTTTG 161 AACTCTTTTTCACTCCTTAGGCCTTGGGCGGGGTTGCCCTGGGGTCATCTGGAGCAGAGAGTGGCGTGGATTTTTTTTTC 241 TCCAAAACATAAAAAATAATAATAACGAATTAATTAAAAAAAAAAAGAGCCTTTCCAGGCTCCAGCCCAGACACGGACCA 321 GCCATGCACCCGCCGGCCACCGTGGCCCCAGCATGAATGTACCTGGACACTATTAATCCCCTCCCTCATTTGGTTCTTGG 401 AGGGCTAGGGAGGGGAGTTTTTTGTTTGTTTCCTTAGGCGGGAACTGCAAACAGGAACTGGAACAGAGACTACTGTTCGT 481 TCAGTCCACTGGTCTATGAGGTTTCAAATGCTTGCCCAGCATGGTCTCAAATGTCTAGATTAATTTAATAACTTTTTGAA 561 ATCACAGAGTAGGTTTGCACCAATGAAACCCAAGAACTCCACAGACACTCACGAGGTTATATCCGTTTCTTTGTATCTAT 641 ATCAACGTATACTTCTTGAAGACTGTATACGTGCGTATAGATAAGTAGATATTATATATATATATATATACATATATATA 721 CATGGATATATAAAGTTCCTTTGCCGGCATGTTGCCTTGTTTCTGCTTAAATTGCTCTATTTTAACTTATGTCCTAAAAG 801 AAGAATGTAATTTGTTTACAAACCTGTAGATAATGTCTTTGGCTATTTGTGTGGTTTAAGGACACTGGTGGCCAAGATGC 881 TTACAAACAGCTCGGGCCCAACAGACACATCCCCTGGATTGCATCCTTGAAGTTTTACGATAGCCATGCTCTGATTTTTG 961 CCTGCTATTTCCGTTCAATAATGTCACTACTGTGGGAAGCTCAGGCAGAAAGCCAACGGCTCCCAAGGATCCACCCTGAG 1041 GAGCTAAGCAACGCGCTCGCTCACTCCACCGTAGACAAGGGAGAAGAGGAGAGAAGGCTTCCTGGGTTTGCAACACGGCC 1121 GTCCAGGTCTGGTGACGTCAACGTCTGTAGTGCACCCGGAGAAGGAAGACTTTTCTCTCAATGAAACTCGCTTGAGTTTA 1201 CAGAGAGCATTTCAGAACTGAGTTGTCTTTGGCACTGTCTGTGAGTCAAGGTAGTGTTCAGATATTACAAATGCTATTGT 1281 GTTGAATTTTTTTTTTTTTTTAGTTAGTAATTTAGAAGTTTCTTTTCTTATAAACGGCAGCATAGACACTGCTGACATAC 1361 TGGATGAGGGTTGGTACGGCTTGCTGCTTTTGTTTTTTTTTTTTTTCTTTTTGAAGAAGAATAGCCTTTTTTCTCTGCAC 1441 TATTTAGATCCGAATGAACCTTATAATGTGTACATTGAGATGTATTCAGTGTGATTTTTAAACCAAATTGTCTTCCTGTA 1521 GTTACAATATATACTGTAGCCTTTTAACAGCAAGTCCTGCTTTCCCAGACAGAAAGCCATTCTGATATCTTCCCATATCA 1601 CAGGTGAGAAAAGGTGGCTATCCCCTCTCCCAACAATAACAGCACTAGTTATCCCACTTAATAAGAGCTTGTCTGTCGGC 1681 CTCTTACTGCTAAGCACTTTGTGGGTCTCAGCTTTTTTTCATAAAAGAACTTTTGTATTTAATACAAAGTTTGCTTTGAG 1761 ACTTTTCAGCATACAATCTTTTTCCATAAACTTGTACAGTGCAAAAGACATTTTGAATACCATGACCGATGATGTCCCGT 1841 GCTTCGAGGAAATCAAACACTTTCCGCCTCACTTGTGAACTCCATCCTTCACTCTCTCCCTCCTCACAATCGCTCCTCCT 1921 CGCTCTTCAGCCTGGCCCCCCAGCCCTCCTCCAGGCCCAGAGACCTCTTCACTAAACAAGATGACAGCCACTTGGGAAAA 2001 GAGCCATAGTCAGCTGGGAGGGCCCACGTCTGGATGGCTGTGAAAAACTTGAGTTCTTGGTTTGGGCTTCAAAGTCTGCC 2081 CATCCCACCTGGCCATAATCTTTCTATAAGGAAGAATATCTCTGAAGGATTCTGATTGTATCCAGGAGAGAGAGAGAGCT 2161 ACCTCTCCAGCAGGTGGACCAGCCCTAGATGTACTCACTGGATTCCAGTACAGACACCACCAGAGCCAGTCCATAGTACC 2241 CCTCCAAGGGAGGGAAGGAAACCCGGGGCTGCCTTGGAACAGGATAGGTTTTTGGTTTGGTTTTGTTGTTGTTGTTGTTG 2321 TTGTTGCTGCTGCTGCTGTTGTTGTTTGATTGGTTTGGGACTTTTGGTGGGGAGTCCTTTGTCACATTTTTCATCCTGCC 2401 CTCCTTCATTCAACCATGCATCTATGACCTCATTCCATGCCACCAGGGTTCTTGCTCTTAACAAACCGGGGTCCTCGGGC 2481 TTTGGAACCAGGCCTCCAGGGCAAAGAGGAAGGGGTTCTCTGAGCAGAGCCAGGTTCTCAGACAGGAGCAGAGGAAACTA 2561 GCAAGGAGGCCTGACATTAGTGCTGGCTTCCCGGTGTCAGGAATGAGAGATAGCCTATGCCCCAGCCCCTCACTCTCACA 2641 CTCTTCCATACACACACACACCTACACAGGAGATGGTTGGTTTGTCAGAACTCACTGTAATACACAAGCTTGCACTTCTG 2721 CGTCCTATATCTAGCAGCATGGGATACGTTTGGCAGTTCACCCCATTAGGGGGTCAATAATTTATGACCATTCATCTGTT 2801 TTTATGAATTTTTTTATCTAGACAATAATTGTAAATAAAGAATTCACCGTCTCTGCTCATTTAATACTATGCAATGGTTA 2881 TGTTTTCCATGGCTGGCTCTTCTGGCTCACATAGGTGTTTCTGATGTGTCTATGGTATTTAAAAAAAAATCAAGCAGAAA 2961 TAGGAAATCTCTACTCTTTTCTAGCGTGGCCCCCACCCCCTTCTTTCCTGTCCTCTGCATTCTGTAAGTGCATCAATCCC 3041 CTAGCCTGTCAGATAACTGAGAAAACACAGGTGAGCATCCAGCAGGGGACCTGAACTTTGGCTCTGGCTACTTCAGAGTC 3121 ACCCATCTGTGGAGGGATAGGGAGAGGCTCAACTTGCTGCTCCCAGCTATCCAGGATTGAGGAGCAGCCTCCATGTCTCC 3201 ACCCACCCATGCTCTCCTATCCTCAACCCAACCACAGCAGAGCTGACTGGAGGGAGGTGCCCTATTTCTGAGAGTGGATG 3281 TGGCACTGGCTGCTCCCAAGCCAGAGCCCATCCTATCCTGGGTCCTCTGGTTAATAAAGAACCACTGTGTCCCCATGCCT 3361 GTTGAAAAGCCACCTTTGCCTTCTCCTAATTTTTTACACAGACTTCAGTCCAACTCTAGAATTTCTCTTTCACTCCCTTA 3441 TCTGGCACCAACCACATGTTCTAATTACTGTCCCTCTCAAACATGTTAGTGTACGGCAGGGGAGTAAGTCCCCCTCCCTG 3521 TTCACAAGATTTCCCCACCCCACCCCCATCTGTTCTTCTGAAGAAATACTAAGTTTTGCCAGATCCTCCAACCTTCTCTT 3601 ACTCCAGACTCTGGGCCCTGTTGCTGTGTGTGCCACCCCCACCCCCATTGTAATCACTGTCCACTGAGATCCTCTATGTG 3681 CAGAATGTCCTATGAGAACAGACAAAGCAACACCTGAATTCTGAGAAGCTATCAACTTACTTGTCCCCTAAGCCCCGGAA 3761 TTGTCGAGAGAGACCACCAAGCCCCACCTAACAAGTCATCGCCTGTGGTTGTCCCAGAGCAAGCCCCCATATGCTCCTTG 3841 TCTGGATGGGAAAGGAAGACCTCTCCCAGGCCCAGTACTTGGACAGAACATTCCGACTCATCAGACCCACACAACAGAGG 3921 GACAGAGGGACAGTGGGACAGAGGGACGTTTTCTGTCTGCCTTTTCTAAACTGGCTTTTGGTCATTTTATTTGGGTTACT 4001 GGGAGTCATCTCTTATTCAGAGTTTTAACACCTTTGGGATACAAGAATGTCTTGCCTGGATGTCGTTGCACCCTTGATGT 4081 AGCTATAGGAGGTTGCCAACTGAACCACACACTGACAAGCTTTCCACCCAACACACTGACAGTTTTCCACCTGAGGCCCC 4161 ACCCTTGGAGAACCCTAGGAGTGAGGATTCTTCTAGAAGCACCAAGGCCACACTCAGACCCTAAAAGTTCCCATGTGTTT 4241 TCCAAGGTCCAAATGAAGCCCTCTGATTTAATATAGAGATCCGACCCACCCAAGGCATGGGACCCCAGGCCCTGGGTAGC 4321 TGCCATCATCCCCTGCTCCCAAAAACAAAAGGTTTGAGGCTGCTTGGGCCCTTCCAGGCCCTTGGTCTGTTTTGTAACGT 4401 CTGTGGTGCTCTCCCTCCAGGGCCCCTCCTCTCGGGGGGTCACCACACTCTGCTATCTCTCGTGTGCACATCTTTTATAA 4481 CGGAGTAGCGAGGGAATGGTGCCGCCTCCAGCTTCCATAAGCTGCCTGGGCTCTGGGGGGCTCTGGGACAATCGGGGCTG 4561 GGAAGTGACTGTGCTCTTATTGTACACTCTTTATTTCTCTGTATCTCTGGCTTGTGCTCTTTGTAACTAACAGGATTTGT 4641 CTGCCTTTTCAACACTATACTAAGCAATAACAATAAATGCACACATGGAAACGCAGGCATGGTAAAAAAAAAAAAAAAAA 4721 A Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C2C12 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
CLIP-seq Support 1 for dataset GSM1385343 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_DM_Ago2_CLIP-Seq_myotubes |
Location of target site | NM_009723 | 3UTR | GGAUUUUUUUUUCUCCAAAACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
14 mmu-miR-3057-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT580946 | Slc25a46 | solute carrier family 25, member 46 | 2 | 2 | ||||||||
MIRT581084 | Serpinb5 | serine (or cysteine) peptidase inhibitor, clade B, member 5 | 2 | 2 | ||||||||
MIRT584738 | Atp2b2 | ATPase, Ca++ transporting, plasma membrane 2 | 2 | 2 | ||||||||
MIRT591856 | Iffo2 | intermediate filament family orphan 2 | 2 | 2 | ||||||||
MIRT593687 | Sco1 | SCO1 cytochrome c oxidase assembly protein | 2 | 2 | ||||||||
MIRT593742 | Pld5 | phospholipase D family, member 5 | 2 | 2 | ||||||||
MIRT593830 | Klhl31 | kelch-like 31 | 2 | 2 | ||||||||
MIRT593961 | Col4a1 | collagen, type IV, alpha 1 | 2 | 2 | ||||||||
MIRT594311 | Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 2 | 2 | ||||||||
MIRT595177 | Zfp953 | zinc finger protein 953 | 2 | 2 | ||||||||
MIRT598903 | Gla | galactosidase, alpha | 2 | 2 | ||||||||
MIRT603414 | Samd7 | sterile alpha motif domain containing 7 | 2 | 2 | ||||||||
MIRT603667 | Opa3 | optic atrophy 3 | 2 | 2 | ||||||||
MIRT606751 | Tns4 | tensin 4 | 2 | 2 |